The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.

@article{Watz2009TheMS,
  title={The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.},
  author={Henrik Watz and Benjamin Waschki and Anne M Kirsten and Kai-Christian M{\"u}ller and Gunther Kretschmar and Thorsten Meyer and Olaf Holz and Helgo Magnussen},
  journal={Chest},
  year={2009},
  volume={136 4},
  pages={
          1039-1046
        }
}
BACKGROUND The metabolic syndrome is a condition frequently found among individuals > 60 years of age. It predisposes affected individuals to systemic inflammation and physical inactivity. Systemic inflammation and physical inactivity are relevant extrapulmonary markers of morbidity and mortality in patients with COPD. Here, we studied the following: (1) the frequency of the coexisting metabolic syndrome in patients with chronic bronchitis (CB) and COPD of different severities; and (2) its… 
Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.
TLDR
It is concluded that MS, as a comorbidity, occurs in all COPD stages and affects systemic inflammation.
Systemic inflammation and metabolic syndrome in stable COPD patients.
TLDR
The study showed that frequency of metabolic syndrome was higher in stable COPD patients than control subjects and general Turkish population and systemic inflammation was more intense in COPD Patients with metabolic syndrome than without metabolic syndrome.
Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation.
TLDR
The findings suggest that physicians should screen COPD patients for associated MetS and elevated circulatory inflammatory markers and management of these disorders should reduce the risk of cardiovascular morbidity and mortality in these patients.
Systemic inflammation in patients of chronic obstructive pulmonary disease with metabolic syndrome
TLDR
Systemic inflammation which is a common characteristic of both COPD and Metabolic syndrome has been found to be an important contributor towards cardiovascular morbidity and mortality.
Metabolic syndrome in chronic obstructive pulmonary disease
TLDR
Early detection and treatment of MS in COPD patients can prevent development of complications due to the combined effects of both diseases.
COPD and the metabolic syndrome: an intriguing association
TLDR
MS is more likely to be present in a COPD patients, and increased levels of circulatory pro-inflammatory proteins from both the lung and adipose tissue coincide in these patients, which may impact the relative impact of the coexisting COPD and MS.
The effect of metabolic syndrome on outcome of acute exacerbation of chronic obstructive pulmonary disease (COPD)
Background: Metabolic syndrome is a multiorgan disease and it could aggravate other diseases. Its effect on chronic obstructive pulmonary disease needs to be addressed. Aim of the work:  to examine
Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
TLDR
MetS increased the frequency of exacerbations and the medical costs in women with early COPD, and it was higher in women than in men and older and had lower pulmonary function and greater number of comorbidities.
...
...

References

SHOWING 1-10 OF 40 REFERENCES
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
TLDR
The metabolic syndrome was frequent in overweight/obese patients with COPD and obesity in COPD was associated with a spectrum of metabolic and inflammatory abnormalities.
Complex chronic comorbidities of COPD
TLDR
The current authors believe that lung function measurement, noninvasive assessment of cardiovascular and metabolic functions, and circulating inflammatory markers (e.g. C-reactive protein) might help to better characterise patients with COPD.
C-reactive protein in patients with COPD, control smokers and non-smokers
TLDR
CRP levels are raised in COPD patients without clinically relevant IHD and independent of cigarette smoking, and reduced in patients with COPD using ICS, suggesting CRP may be a systemic marker of the inflammatory process that occurs in patientswith COPD.
Raised CRP levels mark metabolic and functional impairment in advanced COPD
TLDR
High sensitivity CRP is a marker for impaired energy metabolism, functional capacity, and distress due to respiratory symptoms in COPD.
Increased systemic inflammation is a risk factor for COPD exacerbations.
TLDR
This study demonstrates that besides lung function impairment systemic inflammation manifested by elevated fibrinogen levels is an independent risk factor for exacerbations of COPD.
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.
TLDR
CRP is a strong and independent predictor of future COPD outcomes in individuals with airway obstruction and among those older than 70 yr with a tobacco consumption above 15 g/d and an FEV(1)% predicted of less than 50.
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
TLDR
C-reactive protein levels in stable chronic obstructive pulmonary disease patients are best correlated with arterial oxygen tension and 6-min walk distance and the strongest negative association with CRP levels is found with Pa,O2 and 6MWD.
Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.
TLDR
Higher values of systemic inflammation and left cardiac dysfunction are associated with reduced physical activity in patients with COPD.
Lung function impairment and metabolic syndrome: the critical role of abdominal obesity.
TLDR
A positive independent relationship between lung function impairment and metabolic syndrome in both sexes is found, predominantly due to abdominal obesity.
...
...